This content is machine translated Obesity as a chronic disease: an interdisciplinary perspective Neurobiological mechanisms of obesity A high-fat and high-sugar diet affects both the homeostatic hunger and satiety signals in the hypothalamus and the hedonic reward system, leading to persistent hunger and a strong craving for...…
View Post 5 min This content is machine translated How do weight loss interventions affect the muscles? Reflective evaluation: do not neglect qualitative aspects Both in the context of exclusively dietary interventions and after bariatric surgery or treatment with GLP(glucagon-like peptide)-1 analogs, there is not only a reduction in weight, but also a loss...…
View Post 6 min This content is machine translated Obesity in the family practice Aim for realistic goals and avoid apportioning blame Morbid obesity is a significant health risk factor and its prevalence has increased in many industrialized countries in recent years. The principles of weight reduction have hardly changed over the...…
View Post 4 min This content is machine translated Obesity Extent of weight reduction is prognostically relevant According to the World Health Organization (WHO), obesity is one of the greatest health risks. With increasing severity, the risk of various concomitant and secondary diseases increases. Obesity-related multimorbidity is...…
View Post 4 min This content is machine translated Case report: Drug-induced hepatitis Rare side effect of tirzepatide therapy The dual glucose-dependent insulinotropic polypeptide (GIP)/glucagon-like peptide 1 (GLP1) receptor agonist triazepatide has shown promise for improving glycemic control and weight loss. However, it can also have undesirable side effects....…
View Post 5 min This content is machine translated Obesity GLP-1-based drugs close the treatment gap The WHO has declared obesity to be a global health problem and weight reduction is an important measure in the prevention and treatment of metabolic diseases such as type 2…
View Post 5 min This content is machine translated Obesity GLP-1 analogs and dual incretin agonists to support weight loss. Pathological obesity is a key risk factor for the development of life-threatening secondary complications. Until recently, bariatric surgery was the only effective method for obesity sufferers to achieve a sustained…
View Post 3 min This content is machine translated GLP-1-RA in type 2 diabetes Broad spectrum of action – weight reduction is also supported GLP-1 receptor agonists promote insulin secretion from pancreatic beta cells, leading to decreased glucose release by the liver and increasing insulin sensitivity. Moreover, they slow down gastric emptying and thus…
View Post 2 min This content is machine translated Obesity Sustainable weight reduction with the help of new therapy options Eat less, move more – obese patients know these recommendations well. However, the implementation is anything but simple. And even if weight loss does occur, the dreaded rebound effect undoes…
View Post 6 min This content is machine translated Type 2 diabetes Better quality of life thanks to modern diabetes therapy The cardiovascular benefit of SGLT2 inhibitors and GLP1 analogues is now considered established, and non-diabetics may also benefit. For optimal results, therapy should be tailored to individual patient characteristics.
View Post 5 min This content is machine translated Obesity Weight reduction is required – is there a new patent remedy? Obesity is a risk factor for diabetes and other diseases. In addition to genetic predisposition, lifestyle factors also play a role. Weight reduction is central – is there a new…
